HAYES CHRISTOPHER G. (General Counsel) sold 13.3% of their position (21.74K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $153.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/23/2024ACC: 0001415889-24-019970
Officer· General Counsel
Since Feb 2020
-21.74K
Net shares
Net seller
$153.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
21.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−21.65K
Price / share
$7.06
Trade value
$152.84K
% of position
13.3%
7/22/2024
163.23K→141.58K
Common Stock
Direct
Shares
−91.00
Price / share
$6.98
Trade value
$635.18
% of position
0.1%
7/23/2024
141.58K→141.49K
Total
Net shares
−21.74K
Net value
-$153.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/22/2024 | S · Sale | −21.65K | $7.06 | $152.84K | 13.3% | 163.23K | 141.58K |
| Common Stock Direct | 7/23/2024 | S · Sale | −91.00 | $6.98 | $635.18 | 0.1% | 141.58K | 141.49K |
| Total | −21.74K | -$153.48K | ||||||
Derivative Transactions0
No derivative transactions reported